Inflammation Reduction Pack
Product Images NDC 69176-010

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Inflammation Reduction Pack (NDC 69176-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tmig, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E766b73-197d-485a-8933-496bd8353fed (0e766b73 197d 485a 8933 496bd8353fed)

Packaging label for Lidocaine 2.5% and Prilocaine 2.5% Cream, USP in a 30 g tube by Actavis. The label includes instructions for topical use, storage conditions, directions to open and close the tube, and a note to pharmacists regarding dispensing with application instructions. Manufacturer is IGI Laboratories Inc., Buena, NJ, and distributor is Actavis Pharma, Inc., Parsippany, NJ.*

FDA Label Image

A852683-87ab-48de-9e58-372c1d7dbc53 (1a852683 87ab 48de 9e58 372c1d7dbc53)

Label for Diclofenac Sodium Delayed-Release Tablets, USP, 75 mg, showing the NDC 0228-2551-06. The label includes manufacturer and distributor information, dispensing instructions for pharmacists, storage conditions, and barcode. The product is packaged as 60 enteric-coated tablets.*

FDA Label Image

B9de085-17a5-4f2c-bced-05aa8f128cfb (2b9de085 17a5 4f2c Bced 05aa8f128cfb)

The label for Inflammation Reduction Pack by TMIG, Inc. shows an Rx only medication with NDC 69176-010-04. The pack contains 60 Ranitidine Tablets USP 150 mg, 60 Diclofenac Sodium Tablets 75 mg, and 60 g Emla Cream with 2.5% Lidocaine and 2.5% Prilocaine. Storage instructions and warnings about keeping out of reach of children are included.*

FDA Label Image

67617d1-45b1-4361-9e80-85ea3a35f16c (367617d1 45b1 4361 9e80 85ea3a35f16c)

Label of Lidocaine 2.5% and Prilocaine 2.5% Cream, USP for topical use only, in a 30 g package. The label includes directions for use, storage instructions, and manufacturing and distribution information listing IGI Laboratories Inc. and Actavis Pharma, Inc.*

FDA Label Image

2936054-43b2-488a-9e14-76bad439bf50 (42936054 43b2 488a 9e14 76bad439bf50)

Chemical structure of the active ingredient shown for the Inflammation Reduction Pack by TMIG, Inc. The image depicts a molecular structure with aromatic rings, chlorine atoms, and a carboxylate group, consistent with a pharmaceutical compound.*

FDA Label Image

98366de-486f-40d8-9564-6663d33da29d (498366de 486f 40d8 9564 6663d33da29d)

FDA Label Image

0203c33-1b03-448e-800c-51155b8ea7af (60203c33 1b03 448e 800c 51155b8ea7af)

Inflammation Reduction Pack by TMIG, Inc. packaging shown. The image depicts a light green and blue carton box labeled with the product name. The label includes the TMIG, Inc. name and product NDC 69176-010. No dosage form or active ingredient is visible on the packaging in the image.*

FDA Label Image

4de2c05-43d5-4094-a5e6-80fdf779fb94 (64de2c05 43d5 4094 A5e6 80fdf779fb94)

Chemical structure diagram showing a molecule with the formula C13H20N2O and molecular weight 220.3. The structure includes a benzene ring with a methyl group and an amide linkage extending to a branched alkyl chain.*

FDA Label Image

1532690-3c61-4f7f-a496-110f26dc2954 (A1532690 3c61 4f7f A496 110f26dc2954)

Chemical structure diagram of the active ingredient with molecular formula C14H22N2O and molecular weight 234.3, showing a benzene ring substituted with two methyl groups and an amide linkage to a diethylamine group.*

FDA Label Image

470f175-8503-4394-a2f0-d388446d11f4 (C470f175 8503 4394 A2f0 D388446d11f4)

The image shows the Inflammation Reduction Pack packaging label from TMIG, Inc. It is a rectangular strip, approximately 1 gram in weight and measuring 1.5 by 0.2 inches. The label appears minimalistic with limited textual details visible.*

FDA Label Image

Bb11ead-e05b-4eef-b02b-81bde5ce8924 (Ebb11ead E05b 4eef B02b 81bde5ce8924)

Chemical structure of the active ingredient in the Inflammation Reduction Pack by TMIG, Inc. The diagram displays molecular groups including rings and functional groups, representing the compound's chemical formula associated with the product.*

FDA Label Image

B337713-eb55-4e83-ae93-bee5a14c8cb5 (Fb337713 Eb55 4e83 Ae93 Bee5a14c8cb5)

Label for Ranitidine Tablets USP 150 mg by Glenmark. The label shows the product contains 100 tablets and includes dosage, storage, and handling instructions. Manufactured by Glenmark Generics Inc., Mahwah, NJ, and distributed by Shasun Pharmaceuticals Limited in India. It includes NDC 68462-248-01 and contact details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.